Suppr超能文献

肺移植后移植物排斥反应的机制。

Mechanisms of graft rejection after lung transplantation.

作者信息

Hsiao Hsi-Min, Scozzi Davide, Gauthier Jason M, Kreisel Daniel

机构信息

aDepartment of Surgery bDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA cDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.

出版信息

Curr Opin Organ Transplant. 2017 Feb;22(1):29-35. doi: 10.1097/MOT.0000000000000371.

Abstract

PURPOSE OF REVIEW

To date, outcomes after lung transplantation are far worse than after transplantation of other solid organs. New insights into mechanisms that contribute to graft rejection and tolerance after lung transplantation remain of great interest. This review examines the recent literature on the role of innate and adaptive immunity in shaping the fate of lung grafts.

RECENT FINDINGS

Innate and adaptive immune cells orchestrate allograft rejection after transplantation. Innate immune cells such as neutrophils are recruited to the lung graft early after reperfusion and subsequently promote allograft rejection. Although it is widely recognized that CD4 T lymphocytes in concert with CD8 T cells promote graft rejection, regulatory Foxp3 CD4 T, central memory CD8 T cells, and natural killer cells can facilitate tolerance.

SUMMARY

This review highlights interactions between innate and adaptive immune pathways and how they contribute to lung allograft rejection. These findings lay a foundation for the design of new therapeutic strategies that target both innate and adaptive immune responses.

摘要

综述目的

迄今为止,肺移植后的结果远差于其他实体器官移植。对肺移植后导致移植物排斥和耐受的机制的新见解仍然备受关注。本综述探讨了近期关于固有免疫和适应性免疫在决定肺移植命运中作用的文献。

最新发现

固有免疫细胞和适应性免疫细胞在移植后协同引发同种异体移植物排斥。中性粒细胞等固有免疫细胞在再灌注后早期被募集到肺移植物中,随后促进同种异体移植物排斥。虽然人们普遍认识到CD4 T淋巴细胞与CD8 T细胞协同促进移植物排斥,但调节性Foxp3 CD4 T细胞、中枢记忆CD8 T细胞和自然杀伤细胞可促进耐受。

总结

本综述强调了固有免疫和适应性免疫途径之间的相互作用以及它们如何导致肺同种异体移植物排斥。这些发现为设计针对固有免疫和适应性免疫反应的新治疗策略奠定了基础。

相似文献

1
Mechanisms of graft rejection after lung transplantation.
Curr Opin Organ Transplant. 2017 Feb;22(1):29-35. doi: 10.1097/MOT.0000000000000371.
2
Adaptive features of innate immune cells and their relevance to graft rejection.
Curr Opin Organ Transplant. 2019 Dec;24(6):664-669. doi: 10.1097/MOT.0000000000000707.
3
Innate immunity in ischemia-reperfusion injury and graft rejection.
Curr Opin Organ Transplant. 2019 Dec;24(6):687-693. doi: 10.1097/MOT.0000000000000709.
4
The innate immune response to allotransplants: mechanisms and therapeutic potentials.
Cell Mol Immunol. 2019 Apr;16(4):350-356. doi: 10.1038/s41423-019-0216-2. Epub 2019 Feb 25.
6
Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.
PLoS One. 2015 May 1;10(5):e0124705. doi: 10.1371/journal.pone.0124705. eCollection 2015.
8
An overview on non-T cell pathways in transplant rejection and tolerance.
Curr Opin Organ Transplant. 2010 Aug;15(4):422-6. doi: 10.1097/MOT.0b013e32833b7903.
9
Innate immunity in heart transplantation.
Curr Opin Organ Transplant. 2009 Oct;14(5):571-6. doi: 10.1097/MOT.0b013e32832e7158.
10
The innate natural killer cells in transplant rejection and tolerance induction.
Curr Opin Organ Transplant. 2008 Aug;13(4):339-43. doi: 10.1097/MOT.0b013e3283061115.

引用本文的文献

1
Extracorporeal membrane oxygenation vs cardiopulmonary bypass in lung transplantation: an updated meta-analysis.
Gen Thorac Cardiovasc Surg. 2025 Mar;73(3):137-146. doi: 10.1007/s11748-024-02114-x. Epub 2024 Dec 21.
2
Chronic Lung Allograft Dysfunction: Clinical Manifestations and Immunologic Mechanisms.
Transplantation. 2025 Mar 1;109(3):454-466. doi: 10.1097/TP.0000000000005162. Epub 2024 Aug 6.
4
Lung transplantation in children.
Turk Gogus Kalp Damar Cerrahisi Derg. 2024 Feb 5;32(Suppl1):S119-S133. doi: 10.5606/tgkdc.dergisi.2024.25806. eCollection 2024 Jan.
6
Plasma concentrations of histidine-rich glycoprotein in primary graft dysfunction after lung transplantation.
Interdiscip Cardiovasc Thorac Surg. 2024 Feb 2;38(2). doi: 10.1093/icvts/ivae021.
7
Effect of β-Nicotinamide Adenine Dinucleotide on Acute Allograft Rejection After Rat Lung Transplantation.
Transplant Direct. 2023 Aug 9;9(9):e1516. doi: 10.1097/TXD.0000000000001516. eCollection 2023 Sep.
8
Screening gene signatures for clinical response subtypes of lung transplantation.
Mol Genet Genomics. 2022 Sep;297(5):1301-1313. doi: 10.1007/s00438-022-01918-x. Epub 2022 Jul 3.

本文引用的文献

1
Update on Chronic Lung Allograft Dysfunction.
Curr Transplant Rep. 2016 Sep;3(3):185-191. doi: 10.1007/s40472-016-0112-y. Epub 2016 Aug 2.
3
The Role of Neutrophils in Transplanted Organs.
Am J Transplant. 2017 Feb;17(2):328-335. doi: 10.1111/ajt.13940. Epub 2016 Jul 25.
4
Noninvasive Imaging of CCR2 Cells in Ischemia-Reperfusion Injury After Lung Transplantation.
Am J Transplant. 2016 Oct;16(10):3016-3023. doi: 10.1111/ajt.13907. Epub 2016 Jul 14.
5
Mast cell phenotypes in the allograft after lung transplantation.
Clin Transplant. 2016 Jul;30(7):845-51. doi: 10.1111/ctr.12758. Epub 2016 Jun 22.
6
Role of TLRs and DAMPs in allograft inflammation and transplant outcomes.
Nat Rev Nephrol. 2016 May;12(5):281-90. doi: 10.1038/nrneph.2016.41. Epub 2016 Mar 30.
7
Mechanisms of lung ischemia-reperfusion injury.
Curr Opin Organ Transplant. 2016 Jun;21(3):246-52. doi: 10.1097/MOT.0000000000000304.
8
Role of Toll-Like Receptor 3 in Lung Ischemia-Reperfusion Injury.
Shock. 2016 Oct;46(4):405-11. doi: 10.1097/SHK.0000000000000600.
9
Circulating Cell Death Biomarkers May Predict Survival in Human Lung Transplantation.
Am J Respir Crit Care Med. 2016 Jul 1;194(1):97-105. doi: 10.1164/rccm.201510-2115OC.
10
Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection.
J Clin Invest. 2015 Nov 2;125(11):4255-68. doi: 10.1172/JCI79693. Epub 2015 Oct 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验